Robb Gary Charles sold $1.2M of CORT (indirect holdings)
Robb Gary Charles (Chief Business Officer) sold 10,000 indirectly-held shares of CORCEPT THERAPEUTICS INC (CORT) at $116.26 ($1.16M total) on 2026-08-17.
How this was made
The 30-second read
Why it matters
Traders may briefly reassess sentiment around insider behavior, but there is no new operational or financial information in the text.
Market read
A CBO insider open-market sale of $1.16M worth of CORT shares was disclosed, with no 10b5-1 plan cited.
What to watch
The filing notes the sale was open-market and indicates no pre-arranged 10b5-1 plan, which can increase headline sensitivity even if the economic signal is weak.
Background
This is an SEC Form 4 insider transaction disclosure for Corcept Therapeutics, reported via EDGAR.
Ticker impact
Corcept Therapeutics disclosed an insider open-market sale of 10,000 shares by CBO Robb Gary Charles at $116.2572 on 2026-08-17.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.
Form 4 provides transaction details (size, price, post-sale holdings) but does not include new company performance, guidance, or regulatory/contract developments.
Market effects
No direct sector read-through; this is company-specific insider trading disclosure.
None indicated.
None indicated.
Counterpoint
The sale may be driven by personal liquidity needs and does not necessarily signal reduced confidence, especially without any accompanying negative company-specific news.
Key entities
- issuerCORCEPT THERAPEUTICS INC
Company that filed the Form 4 insider transaction disclosure.
- insiderRobb Gary Charles
Chief Business Officer who sold shares.
